FRANKLIN LAKES, N.J., March 4, 2019 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it will present at the Barclays Global Healthcare Conference on Tuesday, March 12, 2019, at 2:05 p.m. ET. A live webcast of BD’s presentations can be accessed from the BD corporate website... Read more
FRANKLIN LAKES, N.J., Feb. 15, 2019 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it will present at Leerink Partners 8th Annual Global Healthcare Conference on Thursday, February 28, 2019, at 10:00 a.m. ET. A live webcast of BD’s presentation can be accessed from the BD... Read more
FRANKLIN LAKES, N.J., Jan. 24, 2019 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced the U.S. Food and Drug Administration 510(k) clearance of its second generation BD Nano™ pen needle, designed for more reliable subcutaneous injection depth. BD Nano™ 2nd gen pen needles offer people who inject diabetes... Read more
FRANKLIN LAKES, N.J., Jan. 17, 2019 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported preliminary financial results for the first fiscal quarter ended December 31, 2018. Subject to the completion of its financial closing processes, the company expects quarterly revenues of $4.160 billion for the first fiscal quarter ended... Read more
FRANKLIN LAKES, N.J., Jan. 15, 2019 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a global medical technology company, announced today that it will host a live webcast of its Annual Meeting of Shareholders on Tuesday, January 22, 2019, at 1 p.m. (ET). The webcast can be accessed from the BD corporate website at http://www.bd.com/investors/ and... Read more
FRANKLIN LAKES, N.J., Dec. 21, 2018 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it will present at the following upcoming investor healthcare conferences: Goldman Sachs Healthcare CEOs Unscripted: A View From The TopJanuary 3, 20198:45 a.m. ET 37th Annual J.P. Morgan Healthcare ConferenceJanuary 9,... Read more
FRANKLIN LAKES, N.J., Dec. 20, 2018 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the U.S. Food and Drug Administration 510(k) clearance of its BD MAX™ enteric viral panel, a molecular diagnostic test for the direct qualitative detection and differentiation of enteric viral pathogens that cause... Read more
BD FACSLyric™ Flow Cytometer is First BD Product to Earn UL Cybersecurity Assurance Program Certification FRANKLIN LAKES, N.J., Dec. 11, 2018 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the completion of an enterprise level cybersecurity assessment from UL. This independent assessment evaluates corporate cybersecurity programs and policies to... Read more
FRANKLIN LAKES, N.J., Dec. 11, 2018 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the completion of an enterprise level cybersecurity assessment from UL. This independent assessment evaluates corporate cybersecurity programs and policies to ensure that all medical devices developed by a company are built with robust... Read more
FRANKLIN LAKES, N.J., Nov. 29, 2018 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of a new software application designed to help hospitals and health systems identify drug diversion at the 2018 American Society of Health-System Pharmacists (ASHP) Midyear Meeting. Addiction to prescription narcotics in... Read more